HIP
NVO

Harrell Investment Partners’s Novo Nordisk NVO Stock Holding History

Harrell Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
16,042
+1,119
+7% +$48.1K 0.17% 93
2026
Q1 		$548K Buy
14,923
+2,047
+16% +$97K 0.13% 106
2025
Q4 		$655K Sell
12,876
-1,291
-9% -$66K 0.15% 91
2025
Q3 		$786K Buy
14,167
+775
+6% +$45.4K 0.19% 79
2025
Q2 		$924K Buy
+13,392
New +$911K 0.23% 67

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Harrell Investment Partners's NVO Position: Q2 2026 in Review

Harrell Investment Partners increased its Novo Nordisk (NVO) stake by 7.5% in Q2 2026, buying an estimated $48.1K and bringing the position to 16,042 shares worth $769K. The position accounts for 0.17% of the portfolio, ranked #93.

Harrell Investment Partners first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $924K in Q2 2025. 314 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Harrell Investment Partners held 16,042 shares of Novo Nordisk worth $769K as of Q2 2026.
  • Harrell Investment Partners bought 1,119 Novo Nordisk shares in Q2 2026, an estimated $48.1K.
  • Novo Nordisk made up 0.17% of Harrell Investment Partners's portfolio in Q2 2026, its #93 holding.
  • Harrell Investment Partners first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Harrell Investment Partners's Novo Nordisk position peaked at $924K in Q2 2025.
  • 314 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harrell Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.